fenofibric acid has been researched along with Diabetic Retinopathy in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourne, PC; Dou, X; Duerfeldt, AS; Ma, JX; Nath, D; Nurmemmedov, E; Shin, H | 1 |
| Chen, Q; Deng, G; Du, Y; Ma, JX; Ma, X; Matlock, G; Meng, T; Qiu, F; Shao, Y; Wang, X; Wu, W; Xu, Q; Zhou, K | 1 |
| Bogdanov, P; Carvalho, AR; Corraliza, L; Hernández, C; Simó, R | 1 |
| Ansquer, JC; Aubonnet, P; MacuFEN Study Investigators, FT; Massin, P; Peto, T | 1 |
| Nie, J; Wang, F; Wang, H; Zhang, C | 1 |
| Garcia-Ramírez, M; Hernández, C; Palomer, X; Simó, R; Vázquez-Carrera, M | 1 |
| Hernández, C; Kim, D; Roy, S; Simó, R | 1 |
| Bose, N; Kishan, AU; Modjtahedi, BS; Morse, L; Papakostas, TD; Vavvas, DG | 1 |
| Liu, IM; Liu, WY; Tzeng, TF | 1 |
| Corraliza, L; Garcia-Ramírez, M; Hernández, C; Simó, R; Villarroel, M | 1 |
2 review(s) available for fenofibric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
Topics: Animals; Blood-Retinal Barrier; Diabetic Retinopathy; Erythropoietin; Fenofibrate; Humans; Insulin-Like Growth Factor Binding Protein 3; Macular Edema; Protective Factors; Pyrazines; Sitagliptin Phosphate; Triazoles; Vascular Endothelial Growth Factor A | 2014 |
Lipids and Diabetic Retinopathy.
Topics: Diabetic Retinopathy; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids | 2016 |
1 trial(s) available for fenofibric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Effects of fenofibric acid on diabetic macular edema: the MacuFen study.
Topics: Anticholesteremic Agents; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Female; Fenofibrate; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triglycerides; Visual Acuity | 2014 |
7 other study(ies) available for fenofibric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARα Agonists as Leads for Retinal Disorders.
Topics: Animals; Benzylamines; Capillary Permeability; Cell Line; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Drug Discovery; Humans; PPAR alpha; Rats; Retinal Diseases; Streptozocin | 2020 |
Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Topics: Animals; Capillary Permeability; Choroidal Neovascularization; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drug Delivery Systems; Drug Liberation; Fenofibrate; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Leukostasis; Mice; Mice, Knockout; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Inbred BN; Retina; Streptozocin; Tissue Distribution; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2019 |
Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetes.
Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Excitatory Amino Acid Transporter 1; Fenofibrate; Humans; Male; Mice; Retinal Degeneration | 2015 |
Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
Topics: Blood-Retinal Barrier; Capillary Permeability; Cells, Cultured; Cytokines; Diabetic Retinopathy; Down-Regulation; Fenofibrate; Humans; Interleukin-1beta; Interleukin-6; Macular Edema; Retinal Pigment Epithelium; Signal Transduction; Transcription Factor RelA | 2016 |
Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.
Topics: Animals; Anticholesteremic Agents; Blotting, Western; Capillary Permeability; Cells, Cultured; Collagen Type IV; Cyclooxygenase 2; Diabetic Retinopathy; Endothelium, Vascular; Fenofibrate; Fibronectins; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Microscopy, Fluorescence; Rats; Retinal Vessels; Zonula Occludens-1 Protein | 2015 |
Zerumbone, a Bioactive Sesquiterpene, Ameliorates Diabetes-Induced Retinal Microvascular Damage through Inhibition of Phospho-p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways.
Topics: Animals; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Fenofibrate; Glycation End Products, Advanced; Male; Microvessels; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Retina; Retinal Vessels; Sesquiterpenes; Signal Transduction; Streptozocin; Transcription Factor RelA | 2016 |
Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.
Topics: Aged; AMP-Activated Protein Kinases; Biological Transport; Blood-Retinal Barrier; Cell Line; Cell Membrane Permeability; Dextrans; Diabetic Retinopathy; Dose-Response Relationship, Drug; Fenofibrate; Fluorescein-5-isothiocyanate; Glucose; Humans; Hypolipidemic Agents; Interleukin-1beta; Macular Edema; Retinal Pigment Epithelium; Tight Junctions | 2011 |